Insider · CIK 0001709417

Laliberte Kevin

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001709417

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-11-12	Dova Pharmaceuticals Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP, Product Development	DDisposition to Issuer	−50K sh	—	—	0
2019-11-12	Dova Pharmaceuticals Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP, Product Development	DDisposition to Issuer	−10K sh	—	—	0
2019-11-12	Dova Pharmaceuticals Inc.D Disposition to Issuer	Sr. VP, Product Development	DDisposition to Issuer	−4,761 sh	—	—	0
2019-11-12	Dova Pharmaceuticals Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP, Product Development	DDisposition to Issuer	−116K sh	—	—	0
2019-11-12	Dova Pharmaceuticals Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Sr. VP, Product Development	DDisposition to Issuer	−24.8K sh	—	—	0
2019-09-30	Dova Pharmaceuticals Inc.S Sale	Sr. VP, Product Development	SSale	−596 sh	$28.00	−$16.7K	4,761
2019-09-30	Dova Pharmaceuticals Inc.S Sale	Sr. VP, Product Development	SSale	−3,100 sh	$28.00	−$86.8K	5,357
2019-09-25	Dova Pharmaceuticals Inc.S Sale	Sr. VP, Product Development	SSale	−3,100 sh	$20.00	−$62K	8,457
2019-07-31	Dova Pharmaceuticals Inc.S Sale	Sr. VP, Product Development	SSale	−1,389 sh	$15.97	−$22.2K	11,557
2019-07-30	Dova Pharmaceuticals Inc.Employee Stock Option (right to buy)A Award	Sr. VP, Product Development	AAward	+10K sh	—	—	10,000
2019-07-01	Dova Pharmaceuticals Inc.S Sale	Sr. VP, Product Development	SSale	−1,191 sh	$14.17	−$16.9K	12,946
2019-01-04	Dova Pharmaceuticals Inc.A Award	Sr. VP, Product Development	AAward	+7,937 sh	—	—	14,137
2019-01-04	Dova Pharmaceuticals Inc.Employee Stock Option (right to buy)A Award	Sr. VP, Product Development	AAward	+50K sh	—	—	50,000
2018-03-12	Dova Pharmaceuticals Inc.Stock Option (right to buy)A Award	Sr. VP, Product Development	AAward	+50K sh	—	—	50,000
2017-11-06	Dova Pharmaceuticals Inc.Employee Stock Option (Right to Buy)A Award	Sr. VP, Product Development	AAward	+24.8K sh	—	—	24,750
2017-07-05	Dova Pharmaceuticals Inc.P Purchase	Sr. VP, Product Development	PPurchase	+6,200 sh	$17.00	+$105K	6,200

Recent filings

Accepted (ET)
Nov 124
Laliberte Kevin0001209191-19-056036
SEC(opens sec.gov)
Oct 24
Laliberte Kevin0001562180-19-005055
SEC(opens sec.gov)
Sep 274
Laliberte Kevin0001562180-19-004967
SEC(opens sec.gov)
Aug 14
Laliberte Kevin0001209191-19-044032
SEC(opens sec.gov)
Jul 24
Laliberte Kevin0001209191-19-040371
SEC(opens sec.gov)
Jan 84
Laliberte Kevin0001209191-19-002826
SEC(opens sec.gov)
Mar 144
Laliberte Kevin0001209191-18-019559
SEC(opens sec.gov)
Nov 84
Laliberte Kevin0001209191-17-059802
SEC(opens sec.gov)
Jul 74
Dova Pharmaceuticals, Inc.0001209191-17-044264
SEC(opens sec.gov)

Companies

Dova Pharmaceuticals Inc.Sr. VP, Product Development

Address

C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245

DURHAM, NC, 27707